CPT® Code 90723

1. Indications

The DTaP-HepB-IPV vaccine, represented by CPT® Code 90723, is indicated for the prevention of several infectious diseases. The specific indications for this combination vaccine include:

• Diphtheria - A serious bacterial infection affecting the mucous membranes of the throat and nose, which can lead to breathing difficulties, heart failure, and even death.
• Tetanus - A potentially fatal disease caused by a toxin produced by the bacterium Clostridium tetani, leading to muscle stiffness and spasms.
• Acellular Pertussis - A highly contagious respiratory disease caused by the bacterium Bordetella pertussis, characterized by severe coughing fits that can lead to complications, especially in infants.
• Hepatitis B - A viral infection that attacks the liver and can cause chronic disease, liver cirrhosis, and liver cancer.
• Inactivated Poliovirus - A vaccine that protects against poliomyelitis, a viral disease that can cause paralysis and is highly contagious.

2. Procedure

The administration of the DTaP-HepB-IPV vaccine involves several procedural steps to ensure safe and effective delivery. The following steps outline the procedure:

• Step 1: Preparation - Prior to administration, the healthcare provider must gather all necessary materials, including the vaccine vial, syringes, alcohol swabs, and any required documentation. The vaccine should be inspected for any discoloration or particulate matter, ensuring it is suitable for use.
• Step 2: Patient Assessment - The healthcare provider should assess the patient’s medical history, including any previous allergic reactions to vaccines, current health status, and any contraindications to vaccination. This assessment is crucial for ensuring patient safety.
• Step 3: Site Selection - The provider should select an appropriate site for intramuscular injection, typically the deltoid muscle in the upper arm for older children and adults, or the anterolateral thigh for infants and young children.
• Step 4: Injection - After cleaning the injection site with an alcohol swab, the provider will draw the vaccine into the syringe and expel any air bubbles. The needle is then inserted into the muscle at a 90-degree angle, and the vaccine is injected slowly and steadily.
• Step 5: Post-Injection Care - After the injection, the provider should apply gentle pressure to the injection site with a cotton ball or gauze. The patient should be monitored for a brief period for any immediate adverse reactions, and appropriate aftercare instructions should be provided.

3. Post-Procedure

Following the administration of the DTaP-HepB-IPV vaccine, patients may experience mild side effects, such as soreness at the injection site, low-grade fever, or irritability. These effects are generally short-lived and resolve without intervention. It is important for healthcare providers to inform patients or guardians about potential side effects and to advise them on when to seek medical attention, particularly if there are signs of a severe allergic reaction. Additionally, documentation of the vaccine administration, including the date, lot number, and site of injection, should be recorded in the patient's medical record to ensure proper tracking of immunizations.